• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘氨醇 1-磷酸和癌症:甲状腺癌细胞的启示。

Sphingosine 1-phosphate and cancer: lessons from thyroid cancer cells.

机构信息

Department of Biosciences, Åbo Akademi University, Tykistökatu 6A, 20520 Turku, Finland.

出版信息

Biomolecules. 2013 May 14;3(2):303-15. doi: 10.3390/biom3020303.

DOI:10.3390/biom3020303
PMID:24970169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4030848/
Abstract

Sphingomyelin is found in the cell membrane of all eukaryotic cells, and was for a long time considered merely as a structural component. However, during the last two decades, metabolites of sphingomyelin, especially sphingosine 1-phosphate (S1P), have proven to be physiologically significant regulators of cell function. Through its five different G protein-coupled receptors, S1P regulates a wide array of cellular processes, ranging from stimulating cellular proliferation and migration, to the inhibition of apoptosis and induction of angiogenesis and modulation of cellular calcium homeostasis. Many of the processes regulated by S1P are important for normal cell physiology, but may also induce severe pathological conditions, especially in malignancies like cancer. Thus, understanding S1P signaling mechanisms has been the aim of a multitude of investigations. Great interest has also been shown in understanding the action of sphingosine kinase (SphK), i.e., the kinase phosphorylating sphingosine to S1P, and the interactions between S1P and growth factor signaling. In the present review, we will discuss recent findings regarding the possible importance of S1P and SphK in the etiology of thyroid cancer. Although clinical data is still scarce, our in vitro findings suggest that S1P may function as a "double-edged sword", as the receptor profile of thyroid cancer cells largely determines whether S1P stimulates or blocks cellular migration. We will also discuss the interactions between S1P- and VEGF-evoked signaling, and the importance of a S1P1-VEGF receptor 2 complex in thyroid cancer cells.

摘要

鞘磷脂存在于所有真核细胞的细胞膜中,长期以来一直被认为仅仅是一种结构成分。然而,在过去的二十年中,鞘磷脂的代谢产物,特别是 1-磷酸鞘氨醇(S1P),已被证明是细胞功能的生理上重要的调节剂。通过其五个不同的 G 蛋白偶联受体,S1P 调节广泛的细胞过程,从刺激细胞增殖和迁移,到抑制细胞凋亡和诱导血管生成以及调节细胞钙稳态。S1P 调节的许多过程对正常细胞生理学很重要,但也可能诱导严重的病理状况,特别是在癌症等恶性肿瘤中。因此,理解 S1P 信号转导机制一直是众多研究的目标。人们对理解鞘氨醇激酶(SphK)的作用,即磷酸化鞘氨醇生成 S1P 的激酶,以及 S1P 与生长因子信号之间的相互作用也表现出极大的兴趣。在本综述中,我们将讨论最近关于 S1P 和 SphK 在甲状腺癌发病机制中的可能重要性的发现。尽管临床数据仍然匮乏,但我们的体外研究结果表明,S1P 可能作为一把“双刃剑”发挥作用,因为甲状腺癌细胞的受体谱在很大程度上决定了 S1P 是刺激还是阻断细胞迁移。我们还将讨论 S1P-和 VEGF 引发的信号之间的相互作用,以及 S1P1-VEGF 受体 2 复合物在甲状腺癌细胞中的重要性。

相似文献

1
Sphingosine 1-phosphate and cancer: lessons from thyroid cancer cells.鞘氨醇 1-磷酸和癌症:甲状腺癌细胞的启示。
Biomolecules. 2013 May 14;3(2):303-15. doi: 10.3390/biom3020303.
2
Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.免疫细胞中的鞘氨醇激酶信号传导:作为新型治疗靶点的潜力
Biochim Biophys Acta. 2008 Jan;1784(1):66-75. doi: 10.1016/j.bbapap.2007.07.013. Epub 2007 Aug 14.
3
Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.1-磷酸鞘氨醇诱导的Flk-1反式激活通过S1P1/S1P3依赖性β-抑制蛋白/c-Src途径刺激小鼠胚胎干细胞增殖。
Stem Cell Res. 2014 Jan;12(1):69-85. doi: 10.1016/j.scr.2013.08.013. Epub 2013 Sep 7.
4
Roles of sphingosine-1-phosphate signaling in cancer.鞘氨醇-1-磷酸信号传导在癌症中的作用。
Cancer Cell Int. 2019 Nov 14;19:295. doi: 10.1186/s12935-019-1014-8. eCollection 2019.
5
Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.鞘氨醇激酶、1-磷酸鞘氨醇与细胞凋亡
Biochim Biophys Acta. 2002 Dec 30;1585(2-3):193-201. doi: 10.1016/s1388-1981(02)00341-4.
6
Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.1-磷酸鞘氨醇与ML-1滤泡状甲状腺癌细胞中血管内皮生长因子信号传导之间的相互作用。
Endocr Relat Cancer. 2008 Jun;15(2):521-34. doi: 10.1677/ERC-07-0253.
7
Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy.在癌症治疗药物研发中靶向鞘氨醇激酶/1-磷酸鞘氨醇信号轴
Cancers (Basel). 2021 Apr 15;13(8):1898. doi: 10.3390/cancers13081898.
8
Targeting sphingosine-1-phosphate signaling for cancer therapy.针对鞘氨醇-1-磷酸信号通路的癌症治疗策略。
Sci China Life Sci. 2017 Jun;60(6):585-600. doi: 10.1007/s11427-017-9046-6. Epub 2017 May 27.
9
FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.FTY720(芬戈莫德)可减弱基础状态下以及1-磷酸鞘氨醇诱发的甲状腺癌细胞侵袭。
Endocr Relat Cancer. 2016 May;23(5):457-68. doi: 10.1530/ERC-16-0050. Epub 2016 Mar 2.
10
Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.肿瘤抑制型鞘氨醇-1-磷酸受体-2 拮抗肿瘤促进型鞘氨醇-1-磷酸受体-1 和鞘氨醇激酶 1——藏在幕后的海德。
Am J Cancer Res. 2011;1(4):460-81. Epub 2011 Feb 16.

引用本文的文献

1
UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.UDP-葡萄糖神经酰胺葡萄糖基转移酶激活 AKT,促进乳腺癌细胞的增殖和多柔比星耐药性。
Cell Mol Life Sci. 2018 Sep;75(18):3393-3410. doi: 10.1007/s00018-018-2799-7. Epub 2018 Mar 17.
2
Pleiotropic effects of sphingosine-1-phosphate signaling to control human chorionic mesenchymal stem cell physiology.鞘氨醇-1-磷酸信号转导的多效性作用控制人绒毛膜间充质干细胞的生理机能。
Cell Death Dis. 2017 Jul 13;8(7):e2930. doi: 10.1038/cddis.2017.312.
3
Radiation and Thyroid Cancer.

本文引用的文献

1
Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells.鞘氨醇 1-磷酸和人 ether-a'-go-go 相关基因钾通道调节人甲状腺未分化癌细胞的迁移。
Endocr Relat Cancer. 2012 Sep 21;19(5):667-80. doi: 10.1530/ERC-12-0092. Print 2012 Oct.
2
Extracellular and intracellular sphingosine-1-phosphate in cancer.癌症中外源和内源的鞘氨醇-1-磷酸。
Cancer Metastasis Rev. 2011 Dec;30(3-4):577-97. doi: 10.1007/s10555-011-9305-0.
3
Sphingosine-1-phosphate signaling and its role in disease.
辐射与甲状腺癌
Int J Mol Sci. 2017 Apr 26;18(5):911. doi: 10.3390/ijms18050911.
4
Stress responses from the endoplasmic reticulum in cancer.癌症中内质网的应激反应。
Front Oncol. 2015 Apr 20;5:93. doi: 10.3389/fonc.2015.00093. eCollection 2015.
5
Re-configuration of sphingolipid metabolism by oncogenic transformation.致癌转化对鞘脂代谢的重新配置。
Biomolecules. 2014 Mar 14;4(1):315-53. doi: 10.3390/biom4010315.
鞘氨醇-1-磷酸信号转导及其在疾病中的作用。
Trends Cell Biol. 2012 Jan;22(1):50-60. doi: 10.1016/j.tcb.2011.09.003. Epub 2011 Oct 14.
4
Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.肿瘤抑制型鞘氨醇-1-磷酸受体-2 拮抗肿瘤促进型鞘氨醇-1-磷酸受体-1 和鞘氨醇激酶 1——藏在幕后的海德。
Am J Cancer Res. 2011;1(4):460-81. Epub 2011 Feb 16.
5
Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer.鞘氨醇激酶1在人类甲状腺癌中过度表达并促进增殖。
Mol Endocrinol. 2011 Nov;25(11):1858-66. doi: 10.1210/me.2011-1048. Epub 2011 Sep 22.
6
Novel roles for hERG K(+) channels in cell proliferation and apoptosis.hERG K(+) 通道在细胞增殖和凋亡中的新作用。
Cell Death Dis. 2011 Aug 18;2(8):e193. doi: 10.1038/cddis.2011.77.
7
Integration of transient receptor potential canonical channels with lipids.瞬时受体电位经典通道与脂质的相互作用。
Acta Physiol (Oxf). 2012 Feb;204(2):227-37. doi: 10.1111/j.1748-1716.2011.02311.x. Epub 2011 May 27.
8
Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?受体酪氨酸激酶- G 蛋白偶联受体信号平台:走出阴影?
Trends Pharmacol Sci. 2011 Aug;32(8):443-50. doi: 10.1016/j.tips.2011.04.002. Epub 2011 May 24.
9
Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk.离子通道和转运体与癌症。3. 肿瘤细胞-微环境相互作用中的离子通道。
Am J Physiol Cell Physiol. 2011 Oct;301(4):C762-71. doi: 10.1152/ajpcell.00113.2011. Epub 2011 May 11.
10
Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.鞘氨醇 1-磷酸、鞘氨醇激酶和甲状腺细胞中的自分泌钙信号转导。
Acta Physiol (Oxf). 2012 Feb;204(2):151-7. doi: 10.1111/j.1748-1716.2011.02265.x. Epub 2011 May 27.